Cargando…

579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections

BACKGROUND: Providencia is a gram-negative bacillus that colonizes the urinary tract and is often resistant to many antimicrobials. This study aimed to evaluate resistance patterns of Providencia spp (P. spp) and clinical outcomes due to the paucity of topical data. METHODS: A multi-center, descript...

Descripción completa

Detalles Bibliográficos
Autores principales: Kale-Pradhan, Pramodini, Lim, Lauren, Graskewicz, Heather, Malviya, Meenal, COYLE, M E R E D I T H M, Giuliano, Christopher, Johnson, Leonard B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677583/
http://dx.doi.org/10.1093/ofid/ofad500.648
_version_ 1785150164065845248
author Kale-Pradhan, Pramodini
Lim, Lauren
Graskewicz, Heather
Malviya, Meenal
COYLE, M E R E D I T H M
Giuliano, Christopher
Johnson, Leonard B
author_facet Kale-Pradhan, Pramodini
Lim, Lauren
Graskewicz, Heather
Malviya, Meenal
COYLE, M E R E D I T H M
Giuliano, Christopher
Johnson, Leonard B
author_sort Kale-Pradhan, Pramodini
collection PubMed
description BACKGROUND: Providencia is a gram-negative bacillus that colonizes the urinary tract and is often resistant to many antimicrobials. This study aimed to evaluate resistance patterns of Providencia spp (P. spp) and clinical outcomes due to the paucity of topical data. METHODS: A multi-center, descriptive, retrospective chart review of adult patients with P. spp. infections was conducted from January 1, 2020 to May 31, 2022. The primary outcome was to describe the drug resistance patterns of P. spp. isolates. The study’s secondary outcome was to evaluate the clinical outcomes of patients with P. spp infections. RESULTS: Of 312 patients screened, 243 were excluded primarily for polymicrobial infections. The mean age was 70 years and 39 (56.5%) were males. Of the 69 included cases, 46 (66.7%) were P. stuartii, 21 (30.4%) P. rettgerri, and 2 (2.9%) P. alcalifaciens. The most common infections were bacteremia 38 (55.1%), with urinary and wound being the most frequent bacteremia source; followed by 28 (40.6%) urinary tract and 3 (4.3%) wound infections. 45 patients (65.2%) had urinary catheters. Primary antibiotics used for treatment consisted of ceftriaxone, 25 (36.2%), cefepime, 20 (29%), and meropenem, 10 (14.5%). Five of 69 (7.2%) cases were multidrug resistant and required meropenem. Nineteen patients (27.1%) died during their admission but none related to Providencia infections. Ten of the 69 patients (14.5%) were readmitted within 30 days for reasons unrelated to progression or recurrence of Providencia infections. CONCLUSION: Providencia bacteremia was the most common infection. Third generation cephalosporins remain an appropriate choice of antibiotics for P. spp. However, P. stuartii was the only species with multidrug resistance. Future studies should be carried out to confirm this observation. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677583
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106775832023-11-27 579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections Kale-Pradhan, Pramodini Lim, Lauren Graskewicz, Heather Malviya, Meenal COYLE, M E R E D I T H M Giuliano, Christopher Johnson, Leonard B Open Forum Infect Dis Abstract BACKGROUND: Providencia is a gram-negative bacillus that colonizes the urinary tract and is often resistant to many antimicrobials. This study aimed to evaluate resistance patterns of Providencia spp (P. spp) and clinical outcomes due to the paucity of topical data. METHODS: A multi-center, descriptive, retrospective chart review of adult patients with P. spp. infections was conducted from January 1, 2020 to May 31, 2022. The primary outcome was to describe the drug resistance patterns of P. spp. isolates. The study’s secondary outcome was to evaluate the clinical outcomes of patients with P. spp infections. RESULTS: Of 312 patients screened, 243 were excluded primarily for polymicrobial infections. The mean age was 70 years and 39 (56.5%) were males. Of the 69 included cases, 46 (66.7%) were P. stuartii, 21 (30.4%) P. rettgerri, and 2 (2.9%) P. alcalifaciens. The most common infections were bacteremia 38 (55.1%), with urinary and wound being the most frequent bacteremia source; followed by 28 (40.6%) urinary tract and 3 (4.3%) wound infections. 45 patients (65.2%) had urinary catheters. Primary antibiotics used for treatment consisted of ceftriaxone, 25 (36.2%), cefepime, 20 (29%), and meropenem, 10 (14.5%). Five of 69 (7.2%) cases were multidrug resistant and required meropenem. Nineteen patients (27.1%) died during their admission but none related to Providencia infections. Ten of the 69 patients (14.5%) were readmitted within 30 days for reasons unrelated to progression or recurrence of Providencia infections. CONCLUSION: Providencia bacteremia was the most common infection. Third generation cephalosporins remain an appropriate choice of antibiotics for P. spp. However, P. stuartii was the only species with multidrug resistance. Future studies should be carried out to confirm this observation. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677583/ http://dx.doi.org/10.1093/ofid/ofad500.648 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Kale-Pradhan, Pramodini
Lim, Lauren
Graskewicz, Heather
Malviya, Meenal
COYLE, M E R E D I T H M
Giuliano, Christopher
Johnson, Leonard B
579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
title 579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
title_full 579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
title_fullStr 579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
title_full_unstemmed 579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
title_short 579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
title_sort 579. clinical and drug resistance characteristics of providencia spp. infections
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677583/
http://dx.doi.org/10.1093/ofid/ofad500.648
work_keys_str_mv AT kalepradhanpramodini 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections
AT limlauren 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections
AT graskewiczheather 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections
AT malviyameenal 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections
AT coylemeredithm 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections
AT giulianochristopher 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections
AT johnsonleonardb 579clinicalanddrugresistancecharacteristicsofprovidenciasppinfections